-+ 0.00%
-+ 0.00%
-+ 0.00%
Immunovant CEO Eric Venker disposes of common shares worth $3.46 million
Share
Listen to the news
Immunovant CEO Eric Venker disposes of common shares worth $3.46 million
  • Immunovant CEO Eric Venker acquired 92,188 common shares on July 1, 2026 at $14.46 per share.
  • He disposed of 86,629 shares on July 1 at $38.14 per share, cutting holdings to 257,372 shares.
  • Venker sold 3,092 shares on July 2 at $38.48 per share, ending with 254,280 shares.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Immunovant Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001764013-26-000077), on July 06, 2026, and is solely responsible for the information contained therein.

Disclaimer:This article represents the opinion of the author only. It does not represent the opinion of Webull, nor should it be viewed as an indication that Webull either agrees with or confirms the truthfulness or accuracy of the information. It should not be considered as investment advice from Webull or anyone else, nor should it be used as the basis of any investment decision.
What's Trending